DR. JUDY HAMAD MD
Prescription History 1821624321
Dermatology in Indianapolis, IN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. JUDY HAMAD MD, an active Dermatology specialist practicing in Indianapolis, IN. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 240 documented patient claims. Among these therapy options, the most frequently utilized medication is Triamcinolone Acetonide, which accounts for 49 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other IN PrescribersVs. IN Avg |
|---|---|---|---|
| Triamcinolone Acetonide | 49 | $12.17 | ▲ More than typical |
About Triamcinolone Acetonide: This medication is used to treat a variety of skin conditions (such as eczema, dermatitis, allergies, rash). Show more ▾ Triamcinolone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium- to strong-potency corticosteroid. The potency depends on the strength and the form that you use. For details on the potency of your product, ask your pharmacist. An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions. In 2024, this provider wrote 49 Medicare prescriptions for Triamcinolone Acetonide, about 1.4 times the volume of the typical Indiana prescriber of this medication (35.6). Medicare paid an average of $12.17 per fill, versus $9.14 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 57 30-Day Fills standardized to 30-day supplies 1,526 Days of Medication total across all patients in 2024 | |||
| Ketoconazole | 43 | $16.29▼ below IN avg | ≈ Typical |
About Ketoconazole: Ketoconazole is used to treat skin infections such as athlete's foot, jock itch, ringworm, and certain kinds of dandruff. Show more ▾ This medication is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs. Ketoconazole is an azole antifungal that works by preventing the growth of fungus. Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. In 2024, this provider wrote 43 Medicare prescriptions for Ketoconazole, about 80% of the volume of the typical Indiana prescriber of this medication (53.8). Medicare paid an average of $16.29 per fill, versus $16.59 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 49.3 30-Day Fills standardized to 30-day supplies 1,416 Days of Medication total across all patients in 2024 | |||
| Hydrocortisone | 42 | $6.64▼ below IN avg | ▲ More than typical |
About Hydrocortisone: This medication is used to treat a variety of skin conditions (such as insect bites, poison oak/ivy, eczema, dermatitis, allergies, rash, itching of the outer female genitals, anal itching). Show more ▾ Hydrocortisone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a mild corticosteroid. The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. In 2024, this provider wrote 42 Medicare prescriptions for Hydrocortisone, about 1.3 times the volume of the typical Indiana prescriber of this medication (33.5). Medicare paid an average of $6.64 per fill, versus $15.76 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 42 30-Day Fills standardized to 30-day supplies 917 Days of Medication total across all patients in 2024 | |||
| Clindamycin Phosphate | 37 | $33.64▼ below IN avg | ▲ More than typical |
About Clindamycin Phosphate: This medication is used to treat acne. Show more ▾ It helps to decrease the number of acne lesions. Clindamycin is an antibiotic which works by stopping the growth of bacteria. An antibacterial agent that is a semisynthetic analog of LINCOMYCIN. In 2024, this provider wrote 37 Medicare prescriptions for Clindamycin Phosphate, about 1.3 times the volume of the typical Indiana prescriber of this medication (29.4). Medicare paid an average of $33.64 per fill, versus $37.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 44 30-Day Fills standardized to 30-day supplies 1,260 Days of Medication total across all patients in 2024 | |||
| Clobetasol Propionate | 25 | $69.05 | ▼ Less than typical |
About Clobetasol Propionate: This medication is used to treat a variety of skin conditions (such as eczema, psoriasis, dermatitis, allergies, rash). Show more ▾ Clobetasol reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a very strong (super-high-potency) corticosteroid. A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression. In 2024, this provider wrote 25 Medicare prescriptions for Clobetasol Propionate, about 60% of the volume of the typical Indiana prescriber of this medication (41.5). Medicare paid an average of $69.05 per fill, versus $41.17 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27 30-Day Fills standardized to 30-day supplies 795 Days of Medication total across all patients in 2024 | |||
| Dupixent PenDupilumab | 21 | $3,555.64▼ below IN avg | ▼ Less than typical |
About Dupixent Pen: This medication is used to treat certain skin conditions (eczema, prurigo nodularis) and a certain esophagus problem (eosinophilic esophagitis). Show more ▾ It is also used along with other medications to help control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD). In addition, dupilumab may be used to reduce symptoms caused by nasal polyps and the long-term swelling of the sinuses and nasal passage (chronic rhinosinusitis with nasal polyposis). Dupilumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking certain natural proteins in your body (interleukin-4 and interleukin-13) that may cause inflammation and swelling. This medication should not be used to relieve sudden shortness of breath or wheezing. If sudden breathing problems occur, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. Targets the alpha subunit of interleukin-4 receptor. In 2024, this provider wrote 21 Medicare prescriptions for Dupixent Pen, about 72% of the volume of the typical Indiana prescriber of this medication (29.2). Medicare paid an average of $3,555.64 per fill, versus $3,956.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 21 30-Day Fills standardized to 30-day supplies 574 Days of Medication total across all patients in 2024 | |||
| Calcipotriene | 12 | $127.55▼ below IN avg | ▼ Less than typical |
About Calcipotriene: This medication is used to treat psoriasis. Show more ▾ Calcipotriene is a form of vitamin D. It works by slowing down the growth of skin cells. A topical dermatologic for the treatment of moderate plaque psoriasis. In 2024, this provider wrote 12 Medicare prescriptions for Calcipotriene, about 67% of the volume of the typical Indiana prescriber of this medication (17.9). Medicare paid an average of $127.55 per fill, versus $145.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 15 30-Day Fills standardized to 30-day supplies 423 Days of Medication total across all patients in 2024 | |||
| Doxycycline Hyclate | 11 | $16.97 | ▼ Less than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 11 Medicare prescriptions for Doxycycline Hyclate, about a third of the volume of the typical Indiana prescriber of this medication (32.4). Medicare paid an average of $16.97 per fill, versus $12.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 312 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. JUDY HAMAD MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Dermatology prescribing approach at this Indianapolis, IN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among IN prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
